Operating revenues decreased to $3.3 billion in 2013 from $3.39 billion in 2012.
The engineering giant blamed around $87 million in impairments and charges for its swing to a $37.1 million loss for thefourth quarter, although quarterly revenues were also down year-on-year from around $730 million from around $851 million during the period.
The Nasdaq-listed company booked around $39 million in abestos-related provisions during the fourth quarter of 2013.
